Matthew Rosenberg

All filings by Matthew Rosenberg on record concern Nephros Inc. Over a trading history stretching from 6 November 2014 to 9 September 2015, the count stands at 4 filings.

No open-market sale appears; the market trades are 1 purchase. The totals exclude 1 filing filed without an amount. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Outside the open market, there are 2 share grants. Since January 2015: 1 purchase and no sales on the market.

The record was last updated on 11 September 2015 with a share grant in Nephros Inc. The last purchase on record was published on 14 May 2015, which is 4,197 days ago. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. For comparison, the SEC allows two business days to file a Form 4. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.